Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ENZN > SEC Filings for ENZN > Form 8-K on 9-Aug-2013All Recent SEC Filings




Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers.

As previously disclosed, Enzon Pharmaceuticals, Inc. (the "Company") has no intention of resuming any clinical development activities and intends to distribute excess cash, expected to arise from ongoing royalty revenues, in the form of periodic dividends to stockholders. In this regard, the Board of Directors (the "Board") of the Company has determined that a smaller Board is appropriate going forward and has decided to propose certain changes to the Board's composition.

On August 6, 2013, Robert C. Salisbury informed the Board that he will not stand for re-election when his term as a director expires at the Company's next annual meeting of stockholders, which is expected to be held by mid-October 2013. Mr. Salisbury's decision not to stand for re-election was not, to the knowledge of the Company's executive officers, due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

  Add ENZN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ENZN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.